Search for: "HUMAN GENOME SCIENCES, INC."
Results 1 - 20 of 22
Sorted by Relevance | Sort by Date
11 Feb, 2008 8:03 pm
By Christopher P. Singer -- On February 7, 2008, Human Genome Sciences, Inc. (HGS) and
Xencor, Inc. announced that the two companies will enter a collaboration agreement relating to Xencor's proprietary XmAb™ humanization and optimization technologies.
Xencor's technology will be applied to several new monoclonal antibody drug candidates developed against...
2 Aug, 2008 12:54 am
... to Neutrokine for lack of industrial application: Eli Lilly & Co v Human Genome
Sciences Inc; (IPKat), US: FDA seeks input on FDCA § 301(ll) ... (Class 46), Beauty, Beast and Hunchback score dramatic victory - Disney Enterprises Inc. sues
German Concert Promoter: (IPKat), Exemplary damages / wilful infringement - presentation by ... goods: In re American Blanching Co (nonprecedential): (TTABlog), Anadarko - MD Mark
Inc sues Anadarko and Kerr-McGee claiming merger between the companies resulted in ...
22 Jul 10:21 am
... there has been no drug specifically developed for lupus. Following a one year clinical trial, Human Genome Sciences Inc. has announced positive results of lupus patients using Benlysta for more effective treatment ... pain, hair loss, and skin
rash in lupus patients. Encouraged and optimistic, Thomas Watkins, Human Genome's president and chief
executive, noted the need to confirm the study's initial results. The drug may be available as early as the first half of 2010. Please read the full article ...
1 Oct, 2008 12:00 pm
... House of Lords judgment in Angiotech (IPKat commentary here) and the Patents Court judgments in Eli Lilly & Co. v Human Genome Sciences, Inc. (IPKat commentary here), Matsushita Electric (sadly not freely available online, but with IPKat commentary here), Re
Council Regulation (EEC) No 1768/92 (aka Gilead Sciences, commented on the SPC blog here), and the recent (but far from final) chapter in the saga of Zipher v Markem (IPKat
commentary here ...
1 Aug, 2008 7:24 am
Yesterday Mr Justice Kitchin delivered a mega-judgment in Eli Lilly & Co v Human Genome
Sciences Inc, [2008] EWHC 1903 (Pat), yet another significant Patents Court for England and Wales decision on patent ... in that area and who might eventually have found
ways actually to exploit it. * if a substance was disclosed and its function was essential for human health, its identification as having that
function immediately suggested a practical application -- but if its function was not known, or was ...
30 Mar, 2008 8:24 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic
monitoring. Human Genome Sciences Inc. v. Genentech Inc. 1:08-cv-00166; filed
March 25, 2008 in the District Court of Delaware Review...
19 Dec, 2008 8:07 am
... I]n view of the lack of Federal Circuit precedent mandating otherwise, the court declines to review the underdeveloped and incomplete record below as a matter of judicial economy,
and declines to adopt a position that would freely allow litigants to circumvent Board decisions on priority." Human Genome Sciences Inc. v. Genentech Inc., 1-08-cv-00166 (DED December 17, 2008, Memorandum Opinion)
1 Aug, 2008 10:24 am
High Court (Family Division) Z County Council v TS & Ors [2008] EWHC 1773 (Fam) (25 July 2008) SW v SW & Anor [2008] EWHC 1890 (Fam) (31 July 2008) High Court (Patents Court) Re
Council Regulation (EEC) No 1768/92 [2008] EWHC 1902 (Pat) (31 July 2008) Eli Lilly & Company v Human Genome Sciences Inc [2008] EWHC 1903 (Pat) (31 July 2008) Source: www.bailii.org.
4 Aug, 2008 10:57 am
... 02 July 2008) High Court (Commercial Court) Seagate Shipping Ltd v Glencore International AG [2008] EWHC 1904 (Comm) (31 July 2008) High Court (Patents Court) Re Council Regulation
(EEC) No 1768/92 [2008] EWHC 1902 (Pat) (31 July 2008) Eli Lilly & Company v Human Genome
Sciences Inc [2008] EWHC 1903 (Pat) (31 July 2008) Source: www.bailii.org
26 May 9:59 pm
... for a panel consisting of Robert Armitage, Lilly's General Counsel; Gregory Glover of the Pharmaceutical Law Group; and H. Thomas Watkins, President and Chief Executive Officer of
Human Genome Sciences, Inc. In his opening remarks, Dr. Lechleiter (at left) called
this a "historic moment" for the biotechnology and pharmaceutical industries, noting that the swine flu "crisis" might be...
9 Aug, 2008 1:50 am
... particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences: (Managing
Intellectual Property), (Law360), (Rouse & Co International), Restasis ... -infringement declarations: Occupational and Medical Innovations Ltd v Retractable Technologies
Inc: (Mallesons Stephen Jaques), Finkelstein J throws cold water on Registrar's ... mandamus to stay ITC proceeding pending re-examination: In re Freescale Semiconductor
Inc: (Patently-O), (IP Updates), Gillet Outillage - Plaintiffs didn't show ...
23 Dec, 2008 7:00 pm
... of the board of directors and calling for the annual election of all directors: Cumulus Media, Inc.; Human Genome Sciences; O'Charley's Inc.; and Stone Energy Corporation. It won majority votes at eight other ... to allow shareholders an advisory vote
to ratify the compensation of named executive officers was adopted by the Board of Directors of Blockbuster Inc. It was withdrawn at Par Pharmaceuticals based on the Board of
Directors' commitment to adopt the policy in 2009. Social and Environmental ...
19 Dec, 2008 1:00 pm
... for observing patent injunction: Les Laboratoires Servier & Anor v Apotex Inc & Ors (IP finance) US/China: 'Eli Lilly lobbies on counterfeiting and regulatory ... (IP
Dragon) US: Federal judge dismisses patent lawsuit filed by Human Genome Sciences against
Genentech over patent related to type of protein that can be used ... - Canada: Federal Court rejects inequitable conduct doctrine in Canada: Janssen-Ortho Inc v Apotex
(International Law Office) Nexium (Esomeprazole) - US: AstraZeneca to add ...
10 Jun 5:00 am
... Zura's 271 Patent Blog) (Patently-O) (Inventive Step) US: Human Genome Sciences seeks
review of BPAI decision awarding priority of invention to Immunex (now ... (FDA Law Blog) (Patents4Life) Optimum GAT corn - US: BASF Plant Science files patent infringement suit
against Pioneer Hi-Bred International based on ... variation on an old theme (FDA Law Blog) Plavix (Clopidogrel) - EU: Committee for Human
Medicinal Products recommends that six Plavix generics be approved (GenericsWeb) Pulmicort (Budesonide) ...
10 Jun 5:00 am
... Zura's 271 Patent Blog) (Patently-O) (Inventive Step) US: Human Genome Sciences seeks
review of BPAI decision awarding priority of invention to Immunex (now ... (FDA Law Blog) (Patents4Life) Optimum GAT corn - US: BASF Plant Science files patent infringement suit
against Pioneer Hi-Bred International based on ... variation on an old theme (FDA Law Blog) Plavix (Clopidogrel) - EU: Committee for Human
Medicinal Products recommends that six Plavix generics be approved (GenericsWeb) Pulmicort (Budesonide) ...
16 Aug, 2008 2:43 am
... v Pro Laboratories: (Spicy IP), UK: High Court invalidates Human Genome Sciences'
neutrokine-alpha patent: (Patent Docs), US: Hatch-Waxman safe ... needs reform: Occupational and Medical Innovations Ltd v Retractable Technologies Inc: (IP Thinktank), Full
Federal Court finds two countries make an 'international ... - TTAB affirms mere descriptiveness refusal of 'ITALIAN SUSHI': In re Alfredo International Inc (non-precedential):
(TTABlog), Aloft - Aloft voluntarily dismisses two additional companies ...
11 Apr, 2008 9:00 am
... , and patents: (IPBiz), US: Court rules discovery in patent dispute between Human Genome
Sciences and Immunex over type of protein that can be used to detect tumours can ... (Escitalopram) - CAFC decision in Caraco Pharmaceutical Laboratories, Ltd. v. Forest
Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera ( ... claim but not false advertising claim: Trans USA Products,
Inc v Howard Berger Company, Inc: (43(B)log), Tyco - Common law claims of ...
17 Jul 2:31 pm
... lawsuit to eliminate human-gene patents object to Prometheus' patents, which they say cover something that is part of basic science.
Prometheus and several other medical-testing companies (including Myriad Genetics, the defendant in the anti-human- ... the next important
advances in the field of genetics are going to involve more comprehensive tests that can analyze the entire human genome. Watson predicts that these tests will be available for $1,000 or less. But they run the risk of infringing ...
20 Jun, 2008 8:07 am
... : (IP Law360), US: Attempt to concede priority and appeal from BPAI backfires: Human Genome v
Immunex: (Patent Appeal Tracer), US: District Court rules University ... is forbidden: (Afro-IP), Kenya: 2008 Budget: 300 million fund to promote science, technology and
innovation: (IP Kenya), Nigeria: Nigerian Road Safety Commission ... available for series of infringements where work was registered after first infringement: Derek Andrew, Inc v
Poof Apparel Corp: (IP Law Observer), Pressure Products Medical ...
15 Mar, 2008 7:00 am
... related to real time PCR detection of herpes virus: (Patent Docs), US: Genomic research company Open Biosystems settles infringement claims asserted by Sigma-Aldrich ...
Zimbabwe Music Rights Association to lecture Swazi judiciary on copyright: (Afro-IP Science and IP in Addis Ababa - a first hand account from James Nurton of Managing ... moving
patent lawsuits away from East Texas: Micron Technology Inc v Mosaid Technologies Inc: (Techdirt), Are CND patent lawsuits actually a mating call?: (Philip ...
Search on: Blawgs.FM | BlawgSearch Google Co-op |
Blawg.com | Bloglines | Feedster | Google Blog
Search | Technorati | Google | MSN | Yahoo!